Related Experiment Video

Updated: Jul 31, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Progress and prospects in vaccine therapy for gynecologic cancers

K J Gurski1, M A Steller

  • 1Section of Gynecologic Oncology, National Cancer Institute, Bethesda, Maryland, USA.

Oncology (Williston Park, N.Y.)
|December 12, 1997
PubMed

Insights

New therapeutic and prophylactic vaccines are being developed to combat gynecologic cancers by leveraging the immune system. While challenges exist with tumor heterogeneity, these vaccines show promise for preventing and treating cervical, ovarian, and uterine cancers.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Gynecologic cancers, including cervical, ovarian, and uterine cancers, represent a significant health concern.
  • Current treatment modalities for gynecologic cancers have limitations, driving the need for novel therapeutic strategies.
  • The immune system offers a potential avenue for targeting and eliminating cancer cells.

Purpose of the Study:

  • To describe the methodology and rationale behind developing therapeutic and prophylactic vaccines for gynecologic cancers.
  • To explore the potential of immune system-based strategies for cancer prevention and treatment.
  • To discuss the prospects of vaccine efficacy in combating various gynecologic malignancies.

Main Methods:

  • Development of therapeutic vaccines designed to stimulate cellular immunity against malignant tissues.
  • Development of prophylactic vaccines aimed at inducing antibody responses against viral antigens.
  • Analysis of tumor heterogeneity and antigen-presenting mechanisms in the context of vaccine development.

Main Results:

  • Therapeutic vaccines aim to direct immune cells to attack existing cancer cells.
  • Prophylactic vaccines are designed to prevent viral infections that can lead to cancer.
  • Tumor heterogeneity poses a challenge, as not all cancer cells may express the target antigen.

Conclusions:

  • Therapeutic vaccines may be more effective for preinvasive disease or as adjuvant therapy post-treatment.
  • Vaccine-based approaches hold promise for the prevention and treatment of cervical, ovarian, and uterine cancers.
  • Further research into vaccine methodology and rationale is crucial for advancing gynecologic cancer care.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.